levodopa has been researched along with Brain Diseases in 65 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 34 (52.31) | 18.7374 |
1990's | 19 (29.23) | 18.2507 |
2000's | 6 (9.23) | 29.6817 |
2010's | 4 (6.15) | 24.3611 |
2020's | 2 (3.08) | 2.80 |
Authors | Studies |
---|---|
Emrick, L; Hull, M; Parnes, M; Sadat, R | 1 |
Awad, N; Roy, D; Song, J; Zamudio, P | 1 |
Burgess, T; Cunningham, V; Glamuzina, E; Hill, R; Jacobsen, JC; Lehnert, K; Love, DR; Prosser, DO; Robertson, SP; Snell, RG; Swan, B; Taylor, J; Wilson, C | 1 |
Lee, MS; Lyoo, CH | 1 |
Aeby, A; Blau, N; Burlina, A; de Klerk, JB; de Lonlay, P; de Rijk-van Andel, JF; Donati, MA; Geurtz, B; Grattan-Smith, PJ; Haeussler, M; Hoffmann, GF; Jung, H; Kamsteeg, EJ; Kok, F; Leuzzi, V; Megarbane, A; Monaghan, H; Renier, WO; Rondot, P; Ryan, MM; Seeger, J; Smeitink, JA; Steenbergen-Spanjers, GC; van der Knaap, MS; Verbeek, MM; Wassmer, E; Weschke, B; Wevers, RA; Wijburg, FA; Wilcken, B; Willemsen, MA; Zafeiriou, DI | 1 |
Aizaki, K; Okumura, K; Tsuru, T | 1 |
Delfino, MA; Ferrario, JE; Gershanik, O; Mourlevat, S; Murer, MG; Raisman-Vozari, R; Ruberg, M; Stefano, A; Taravini, IR | 1 |
Airas, L; Marttila, RJ; Paavilainen, T; Rinne, J | 1 |
Danielczyk, W | 3 |
Narabayashi, H | 1 |
Wajsbort, J; Youdim, MB | 1 |
Johnson, RT; Price, DL | 1 |
Kameyama, M; Nagata, H; Nakamura, S; Udaka, F; Yamao, S | 1 |
Goetz, CG; Klawans, HL; Tanner, CM | 1 |
Hefti, F; Liebman, J; Melamed, E; Pettibone, DJ; Wurtman, RJ | 1 |
Ciannella, L; Dell'Aria, V; Melone, MA | 1 |
De Tribolet, N; Ghika, J; Regli, F; Uské, A | 1 |
Bressi, S; Caraceni, T; Cortelli, P; Fazio, F; Gentrini, S; Grassi, F; Perani, D; Savoiardo, M; Testa, D | 1 |
Boldry, RC; Chase, TN; Engber, TM | 1 |
Ben Shlomo, Y; Daniel, SE; Magalhães, M; Quinn, NP; Wenning, GK | 1 |
Dasouki, M; Hiari, M; Mubaidin, A; Najim al-Din, AS; Wriekat, A | 1 |
Hossain, MA; Weiner, N | 1 |
Aotsuka, A; Asahina, M; Hirayama, K; Inoue, O; Shinotoh, H; Suhara, T; Tateno, Y; Yamazaki, T | 1 |
Anderson, JJ; Baronti, F; Bravi, D; Chase, TN; Dagani, F; Davis, TL; Ferrari, R | 1 |
Bédard, PJ; Blanchet, PJ; Calon, F; Di Paolo, T; Falardeau, P; Goulet, M; Morissette, M | 1 |
Dike, GL | 1 |
Berardelli, A; Curra, A; Inghilleri, M; Manfredi, M; Marchetti, P; Priori, A; Rona, S | 1 |
Fenu, S; Morelli, M; Ongini, E; Pinna, A | 1 |
Moerlein, SM; Perlmutter, JS | 1 |
Imahori, Y; Kawano, H; Misawa, A; Sawada, T; Takeuchi, Y | 1 |
Cabral, J; Gálvez-Jiménez, N; Hanson, MR | 1 |
Ferger, B; Schmidt, N; Schulz, JB; Teismann, P; Xia, XG | 1 |
Carlsson, A | 1 |
Hagino, K; Ikeda, M; Watanabe, H; Watanabe, K | 1 |
Berendes, K; Dörstelmann, D | 1 |
Moskowitz, MA; Wurtman, RJ | 1 |
Zenkov, LR | 1 |
Morel-Maroger, A | 1 |
Hoehn, MM; Kelts, KA | 1 |
Kato, Y | 1 |
Cler, JM; Feve, JR; Mathé, JF; Mussini, JM; Nomballais, MF | 1 |
Klawans, HL; Lupton, M; Simon, L | 1 |
Anggård, E; Samuelsson, K | 1 |
Forno, LS; Langston, JW; Schober, R | 1 |
Hosfield, WB; Hutton, JT; Levy, BS | 1 |
Buonanno, F; Nardelli, E; Onnis, L; Rizzuto, N | 1 |
Golubev, VL; Iakhno, NN; Veĭn, AM | 1 |
Hirano, F; Kimura, K; Makino, I; Narita, S | 1 |
James, M; Lange, KW; Marsden, CD; Owen, AM; Paul, GM; Robbins, TW | 1 |
Angelberger, P; Brücke, T; Deecke, L; Küfferle, B; Müller, C; Podreka, I; Topitz, A; Wenger, S | 1 |
Neufeld, MY | 1 |
Brooks, DJ; Harding, AE; Ibanez, V; Kocen, RS; Leigh, PN; Marsden, CD; Playford, ED; Sawle, GV | 1 |
Dickey, W; Morrow, JI | 1 |
Chubakov, AR; Gromova, EA; Semenova, TP | 1 |
Boyce, S; Jenner, P; Marsden, CD | 1 |
Imai, H; Komiya, T; Narabayashi, H; Usui, S | 1 |
Adamkov, J; Fundárek, J; Sútorová, D | 1 |
Jankovic, J; Pettigrew, LC | 1 |
Culebras, A; Miller, M | 1 |
Frantz, AG; Suh, HK | 1 |
Ulrich, G | 1 |
Cotzias, GC | 1 |
Williams, R | 1 |
10 review(s) available for levodopa and Brain Diseases
Article | Year |
---|---|
Inhibitory cortical phenomena studied with the technique of transcranial stimulation.
Topics: Brain Diseases; Cerebral Cortex; Diazepam; Dopamine Agents; Electric Stimulation; GABA Modulators; Humans; Levodopa; Magnetics; Movement; Neural Inhibition | 1996 |
PET measurements of dopaminergic pathways in the brain.
Topics: Adrenergic Fibers; Brain Diseases; Cerebrovascular Circulation; Dopamine; Dopamine Agents; Dystonia; Humans; Levodopa; Neural Pathways; Parkinson Disease; Radiopharmaceuticals; Receptors, Dopamine; Schizophrenia; Tomography, Emission-Computed | 1999 |
A paradigm shift in brain research.
Topics: Animals; Antipsychotic Agents; Brain; Brain Diseases; Cerebral Cortex; Corpus Striatum; Dopamine; Humans; Levodopa; Mental Disorders; Neurotransmitter Agents; Synaptic Transmission; Thalamus; Zimeldine | 2001 |
Catecholamines and neurologic diseases (second of two parts).
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Brain; Brain Diseases; Catecholamines; Cerebrovascular Disorders; Dopamine; Dysautonomia, Familial; Dystonia Musculorum Deformans; Hepatic Encephalopathy; Homovanillic Acid; Humans; Huntington Disease; Levodopa; Movement Disorders; Multiple Sclerosis; Nervous System Diseases; Parkinson Disease; Phenylketonurias; Seizures; Spinal Cord Injuries; Torticollis; Tourette Syndrome | 1975 |
[Determination of serum prolactin].
Topics: 5-Hydroxytryptophan; Amenorrhea; Brain Diseases; Chlorpromazine; Female; Galactorrhea; Humans; Hypothalamus; Levodopa; Male; Methods; Pituitary Diseases; Pregnancy; Prolactin; Sleep; Sulpiride; Thyrotropin-Releasing Hormone; Water | 1976 |
[A case of parkinsonism due to pontine and extrapontine myelinolysis].
Topics: Addison Disease; Adult; Brain Diseases; Demyelinating Diseases; Humans; Hyponatremia; Levodopa; Magnetic Resonance Imaging; Male; Parkinson Disease; Pons; Tomography, X-Ray Computed | 1992 |
Drug-induced neurological disorders.
Topics: Antihypertensive Agents; Aspirin; Brain Diseases; Dyskinesia, Drug-Induced; Humans; Levodopa; Nervous System Diseases; Neuromuscular Diseases | 1990 |
Receptor changes during chronic dopaminergic stimulation.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Brain Diseases; Bromocriptine; Dopamine; Humans; Hydroxydopamines; Injections, Intraperitoneal; Levodopa; Neurotransmitter Agents; Oxidopamine; Parkinson Disease; Pergolide; Primates; Pyridines; Receptors, Dopamine; Substance Withdrawal Syndrome | 1988 |
L-DOPA and the control of prolactin secretion.
Topics: Adenoma, Chromophobe; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Brain Diseases; Breast Feeding; Breast Neoplasms; Chlorpromazine; Clone Cells; Coitus; Depression, Chemical; Drug Synergism; Enzyme Inhibitors; Ergot Alkaloids; Estrogens; Female; Haplorhini; Humans; Hypoglycemia; Hypothalamus; Levodopa; Male; Neoplasm Metastasis; Pituitary Gland, Anterior; Pituitary Neoplasms; Pregnancy; Prolactin; Rats; Sleep; Stimulation, Chemical; Stress, Physiological; Thyrotropin-Releasing Hormone; Time Factors; Water-Electrolyte Balance | 1974 |
Fulminant viral hepatitis.
Topics: Acute Disease; Acute Kidney Injury; Amino Acids; Ammonia; Animals; Brain; Brain Diseases; Brain Edema; Cross Circulation; Female; Hemorrhagic Disorders; Heparin; Hepatic Encephalopathy; Hepatitis A; Humans; Levodopa; Liver Regeneration; Prothrombin Time; Swine; Tryptophan | 1974 |
2 trial(s) available for levodopa and Brain Diseases
Article | Year |
---|---|
A new selective suicide inhibitor of peripheral DOPA decarboxylase.
Topics: Aged; Antiparkinson Agents; Brain Diseases; Carboxy-Lyases; Clinical Trials as Topic; Electroencephalography; Female; Humans; Hyperbilirubinemia; Hypertension; Levodopa; Male; Middle Aged; Parkinson Disease | 1984 |
L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction.
Topics: Brain Diseases; Cognition Disorders; Discrimination, Psychological; Female; Frontal Lobe; Humans; Learning; Levodopa; Male; Memory; Middle Aged; Parkinson Disease; Psychomotor Performance; Substance Withdrawal Syndrome | 1992 |
53 other study(ies) available for levodopa and Brain Diseases
Article | Year |
---|---|
A case of treatable encephalopathy, developmental regression, and proximal tremor.
Topics: Brain Diseases; Developmental Disabilities; Dystonic Disorders; Humans; Infant; Levodopa; Male; Treatment Outcome; Tremor | 2021 |
Treatment of unexplained coma and hypokinetic-rigid syndrome in a patient with COVID-19.
Topics: Blood Coagulation; Brain Diseases; Carbidopa; Central Nervous System Stimulants; Cognitive Dysfunction; COVID-19; Critical Care; Drug Combinations; Humans; Hypokinesia; Ischemic Stroke; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Modafinil; Rehabilitation; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Ventilator Weaning | 2021 |
Brain dopamine-serotonin vesicular transport disease presenting as a severe infantile hypotonic parkinsonian disorder.
Topics: Brain; Brain Diseases; Carbidopa; Child; Dopamine; Humans; Levodopa; Male; Parkinsonian Disorders; Polymorphism, Single Nucleotide; Serotonin | 2016 |
Levodopa responsive hemidystonia associated with contralateral nigral lesion.
Topics: Anti-Dyskinesia Agents; Brain Diseases; Dystonia; Female; Functional Laterality; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Substantia Nigra; Tropanes | 2010 |
Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis.
Topics: Age of Onset; Amino Acid Metabolism, Inborn Errors; Brain; Brain Diseases; Catecholamines; Child, Preschool; Disease Progression; Dopamine Agents; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Hypokinesia; Infant; Levodopa; Muscle Rigidity; Mutation, Missense; Phenotype; Promoter Regions, Genetic; Severity of Illness Index; Tyrosine 3-Monooxygenase | 2010 |
[Case of acute brainstem and striatal encephalopathy associated with Mycoplasma pneumoniae infection].
Topics: Acute Disease; Brain Diseases; Brain Stem; Child; Corpus Striatum; Humans; Levodopa; Magnetic Resonance Imaging; Male; Necrosis; Pneumonia, Mycoplasma; Treatment Outcome; Urinary Bladder, Overactive | 2011 |
Differential gene expression induced by chronic levodopa treatment in the striatum of rats with lesions of the nigrostriatal system.
Topics: Animals; Antiparkinson Agents; Behavior, Animal; Brain Diseases; Calmodulin; Carrier Proteins; Cell Count; Corpus Striatum; Cytokines; Dopamine Plasma Membrane Transport Proteins; Female; Functional Laterality; Gene Expression; Gene Library; Immunohistochemistry; In Situ Hybridization; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Myelin Basic Protein; Nerve Tissue Proteins; Oligonucleotide Array Sequence Analysis; Oxidopamine; Radioimmunoassay; Rats; Rats, Wistar; Substantia Nigra | 2004 |
Methanol intoxication-induced nigrostriatal dysfunction detected using 6-[18F]fluoro-L-dopa PET.
Topics: Brain Diseases; Corpus Striatum; Fluorodeoxyglucose F18; Humans; Levodopa; Male; Methanol; Middle Aged; Poisoning; Positron-Emission Tomography; Substantia Nigra | 2008 |
Pharmacotoxic psychoses in patients with neurological disorders in old age.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Brain Diseases; Delirium; Digitalis Glycosides; Diuretics; Humans; Levodopa; Middle Aged; Syndrome | 1984 |
Recent status of stereotaxic surgery.
Topics: Brain Diseases; Humans; Levodopa; Parkinson Disease; Stereotaxic Techniques; Thalamus | 1983 |
Chronic neurological diseases: their societal burdens and potential solutions.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Ataxia; Axons; Brain Diseases; Cerebral Cortex; Chronic Disease; Dopamine; Humans; Huntington Disease; Immunoglobulin G; Levodopa; Motor Neurons; Multiple Sclerosis; Parkinson Disease | 1980 |
Pathologic laughing and crying treated with levodopa.
Topics: Affective Symptoms; Brain Diseases; Crying; Female; Humans; Laughter; Levodopa; Male; Middle Aged | 1984 |
The pharmacology of olivopontocerebellar atrophy.
Topics: Adult; Amantadine; Atrophy; Baclofen; Brain Diseases; Carbidopa; Cerebellar Ataxia; Female; Humans; Levodopa; Male; Middle Aged; Olivary Nucleus; Pons; Propranolol; Syndrome | 1984 |
Aromatic L-amino acid decarboxylase in rat corpus striatum: implications for action of L-dopa in parkinsonism.
Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Brain Diseases; Corpus Striatum; Dopamine; Glutamate Decarboxylase; Kainic Acid; Levodopa; Male; Neurons; Parkinson Disease; Rats; Serotonin | 1981 |
[L-dopa-resistant Parkinson's disease with cerebral atrophy: striato-nigral degeneration?].
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Atrophy; Brain Diseases; Corpus Striatum; Female; Humans; Levodopa; Male; Middle Aged; Nerve Degeneration; Parkinson Disease; Substantia Nigra | 1981 |
L-dopa resistant parkinsonism in an adult woman with a cyst in the posterior fossa.
Topics: Adult; Brain Diseases; Brain Stem; Cranial Fossa, Posterior; Cysts; Dandy-Walker Syndrome; Diagnosis, Differential; Female; Humans; Levodopa; Magnetic Resonance Imaging; Neurologic Examination; Parkinson Disease, Secondary | 1993 |
Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study.
Topics: Atrophy; Brain Diseases; Corpus Striatum; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Male; Middle Aged; Olivopontocerebellar Atrophies; Parkinson Disease; Substantia Nigra; Tomography, Emission-Computed | 1995 |
Influence of previous exposure to levodopa on the interaction between dizocilpine and dopamine D1 and D2 agonists in rats with 6-hydroxydopamine-induced lesions.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Brain Diseases; Dizocilpine Maleate; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Levodopa; Male; Motor Activity; N-Methylaspartate; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1993 |
Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.
Topics: Adult; Aged; Brain Diseases; Cerebellar Diseases; Corpus Striatum; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Olivopontocerebellar Atrophies; Parkinson Disease; Substantia Nigra; Tremor | 1994 |
Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome.
Topics: Adolescent; Adult; Brain Diseases; Carbidopa; Child; Chromosome Aberrations; Chromosome Disorders; Consanguinity; Dementia; Electromyography; Extrapyramidal Tracts; Female; Globus Pallidus; Humans; Immobilization; Levodopa; Magnetic Resonance Imaging; Male; Pedigree; Syndrome | 1994 |
Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biopterins; Brain Diseases; Carbidopa; Corpus Striatum; Cyclic AMP; Disease Models, Animal; Dopamine; Dopamine D2 Receptor Antagonists; Homovanillic Acid; Levodopa; Male; Oxidopamine; Parkinson Disease; Rats; Rats, Inbred F344; Receptors, Dopamine D1; Receptors, Dopamine D2; Sensitivity and Specificity; Substantia Nigra; Time Factors | 1993 |
Dopamine D1 receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study.
Topics: Adult; Aged; Brain; Brain Diseases; Corpus Striatum; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Degeneration; Parkinson Disease; Putamen; Radiography; Receptors, Dopamine D1; Tomography, Emission-Computed | 1993 |
No evidence for altered muscle mitochondrial function in Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Brain Diseases; Female; Humans; Levodopa; Male; Middle Aged; Mitochondria, Muscle; Multienzyme Complexes; NADH Dehydrogenase; Oxygen Consumption; Parkinson Disease; Respiratory Function Tests; Substantia Nigra | 1993 |
Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Autoradiography; Behavior, Animal; Brain; Brain Diseases; Dopamine Agents; Female; Humans; In Situ Hybridization; Levodopa; Macaca fascicularis; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger | 1996 |
Triphasic waves in serotonin syndrome.
Topics: 1-Naphthylamine; Aged; Amantadine; Antiparkinson Agents; Brain Diseases; Carbidopa; Drug Combinations; Drug Therapy, Combination; Electroencephalography; Hallucinations; Humans; Levodopa; Male; Myoclonus; Parkinson Disease; Selective Serotonin Reuptake Inhibitors; Sertraline; Syndrome | 1997 |
Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats.
Topics: Animals; Behavior, Animal; Brain Diseases; Dopamine Agonists; Drug Synergism; Gene Expression; Genes, fos; Levodopa; Male; Oxidopamine; Proto-Oncogene Proteins c-fos; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Dopamine D2; Substantia Nigra; Triazoles | 1997 |
Putaminal necrosis presenting with hemidystonia.
Topics: Antiparkinson Agents; Brain Diseases; Child; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Dystonia; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Levodopa; Magnetic Resonance Imaging; Necrosis; Putamen; Tomography, Emission-Computed; Treatment Outcome | 2000 |
Dopa-resistant parkinsonism, oculomotor disturbances, chorea, mirror movements, dyspraxia, and dementia: the expanding clinical spectrum of hypoparathyroidism. A case report.
Topics: Aged; Antiparkinson Agents; Apraxias; Brain Diseases; Calcinosis; Chorea; Chronic Disease; Dementia; Diagnosis, Differential; Drug Tolerance; Female; Humans; Hypoparathyroidism; Levodopa; Magnetic Resonance Imaging; Oculomotor Nerve Diseases; Parkinsonian Disorders; Stereotypic Movement Disorder; Videotape Recording | 2000 |
Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Methyltyrosine; Animals; Benzazepines; Brain Diseases; Carbidopa; Carrier Proteins; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine D2 Receptor Antagonists; Dopamine Plasma Membrane Transport Proteins; Enzyme Inhibitors; Homovanillic Acid; Levodopa; Male; Malonates; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neuropeptides; Oxidopamine; Rats; Rats, Wistar; Reactive Oxygen Species; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Reserpine; Succinate Dehydrogenase; Sulpiride; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2001 |
[Effects of dopaminergic stimulating agents, caffeine and antipsychotic drugs on rotational behaviour in mice with unilateral striatal 6-hydroxydopamine lesions (author's transl)].
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Brain Diseases; Caffeine; Corpus Striatum; Hydroxydopamines; In Vitro Techniques; Levodopa; Male; Methamphetamine; Methods; Mice; Receptors, Dopamine; Rotation | 1978 |
[Acute pharmacotoxic psychoses in patients with chronic cerebral disorders].
Topics: Aged; Alzheimer Disease; Antidepressive Agents; Antipsychotic Agents; Brain Diseases; Cerebrovascular Disorders; Dementia; Digitalis Glycosides; Diuretics; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Multiple Sclerosis; Parkinson Disease; Psychoses, Substance-Induced | 1979 |
[Pharmacotoxic psychoses in patients with neurological disorders during old age (author's transl)].
Topics: Aged; Antidepressive Agents; Antiparkinson Agents; Antipsychotic Agents; Brain Diseases; Digitalis Glycosides; Diuretics; Humans; Levodopa; Middle Aged; Psychoses, Substance-Induced; Psychotropic Drugs | 1979 |
Unsuccessful treatment with levodopa of a parkinsonian patient with calcification of the basal ganglia.
Topics: Aged; Basal Ganglia; Brain Diseases; Calcinosis; Drug Resistance; Humans; Levodopa; Male; Parkinson Disease | 1978 |
[New trends in clinical neurology].
Topics: Brain; Brain Diseases; Cerebral Cortex; Epilepsy; Evoked Potentials; Humans; Levodopa; Motor Neurons; Movement Disorders; Nervous System Diseases; Neurons; Pain; Radiculopathy; Spinal Nerves; Synaptic Transmission | 1976 |
[Positive effects of L-dopa on a "marginal" symptomatology observed in parkinsonians].
Topics: Aged; Brain Diseases; Female; Frontal Lobe; Humans; Levodopa; Male; Ophthalmoplegia; Paresthesia; Parkinson Disease, Secondary; Reflex, Babinski | 1978 |
Hypothalamic atrophy.
Topics: Adult; Atrophy; Brain Diseases; Cerebellum; Cerebral Ventricles; Humans; Hypertrophy; Hypothalamus; Levodopa; Male; Middle Aged; Pneumoencephalography; Receptors, Adrenergic; Receptors, Dopamine | 1978 |
[Striato-nigral degeneration. Clinical and anatomic study of a case which responded favorably to L-Dopa].
Topics: Aged; Brain Diseases; Cerebral Cortex; Corpus Striatum; Female; Humans; Levodopa; Parkinson Disease; Substantia Nigra | 1977 |
Calcification of the basal ganglia as a cause of levodopa-resistant parkinsonism.
Topics: Basal Ganglia; Brain Diseases; Calcinosis; Computers; Dopamine; Female; Humans; Hypoparathyroidism; Levodopa; Middle Aged; Parkinson Disease; Thyroidectomy; Tomography, X-Ray | 1976 |
Prolonged symptoms of brain dysfunction--adverse effect of levodopa.
Topics: Aged; Benserazide; Brain Diseases; Drug Therapy, Combination; Female; Humans; Levodopa; Parkinson Disease; Time Factors | 1976 |
Idiopathic orthostatic hypotension. Biochemical and pathologic observations in 2 cases.
Topics: 5-Hydroxytryptophan; Aged; Amines; Brain Diseases; Female; Ganglia, Autonomic; Humans; Hydroxyindoleacetic Acid; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Parkinson Disease; Putamen; Spinal Cord; Substantia Nigra | 1975 |
Reye's syndrome.
Topics: Adolescent; Ammonia; Antiemetics; Bilirubin; Blood Glucose; Brain Diseases; Child; Child, Preschool; Electroencephalography; Exchange Transfusion, Whole Blood; Female; Glycerol; Humans; Infant; Levodopa; Male; Neomycin; Peritoneal Dialysis; Prothrombin Time; Reye Syndrome; Steroids; Transaminases | 1975 |
Striato-nigral degeneration. Report of a case with an unusually short course and multiple system degenerations.
Topics: Brain; Brain Diseases; Corpus Striatum; Female; Humans; Levodopa; Middle Aged; Substantia Nigra; Visual Pathways | 1975 |
[The role of disorders of "non-specific systems" of the brain in the pathogenesis of the Parkinsonian syndrome].
Topics: Brain Diseases; Electroencephalography; Electromyography; Humans; Hypnosis; Levodopa; Middle Aged; Parkinson Disease, Secondary; Psychopathology; Reticular Formation; Sleep Stages; Wakefulness | 1975 |
Dopamine D2 receptor imaging with SPECT: studies in different neuropsychiatric disorders.
Topics: Adult; Aged; Aging; Antipsychotic Agents; Benzamides; Brain Diseases; Cerebellum; Corpus Striatum; Frontal Lobe; Humans; Huntington Disease; Iodine Radioisotopes; Levodopa; Middle Aged; Parkinson Disease; Pyrrolidines; Receptors, Dopamine; Receptors, Dopamine D2; Stereoisomerism; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 1991 |
Periodic triphasic waves in levodopa-induced encephalopathy.
Topics: Aged; Brain Diseases; Electroencephalography; Female; Humans; Levodopa; Male; Parkinson Disease | 1992 |
Presynaptic and postsynaptic striatal dopaminergic function in neuroacanthocytosis: a positron emission tomographic study.
Topics: Acanthocytes; Adult; Aged; Brain Diseases; Caudate Nucleus; Cerebellum; Cerebrovascular Circulation; Corpus Striatum; Female; Humans; Levodopa; Male; Middle Aged; Putamen; Receptors, Dopamine; Reference Values; Tomography, Emission-Computed | 1991 |
[The trophic function of the brain monoaminergic system and its importance in pathology].
Topics: 5-Hydroxytryptophan; Animals; Animals, Newborn; Behavior, Animal; Brain; Brain Diseases; Culture Techniques; Levodopa; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Catecholamine; Receptors, Serotonin; Serotonin | 1988 |
[Metrizamide encephalopathy in a child with hydrocephalus--effects of L-threo-DOPS on persistent disturbance of consciousness and L-dopa on extrapyramidal symptoms].
Topics: Basal Ganglia Diseases; Brain; Brain Diseases; Child; Cognition Disorders; Consciousness Disorders; Droxidopa; Electroencephalography; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Hydrocephalus; Levodopa; Metrizamide; Serine; Tomography, X-Ray Computed | 1988 |
[Neurologic and electromyographic findings in chronic manganese encephalopathy].
Topics: Adult; Brain Diseases; Carbidopa; Chronic Disease; Drug Combinations; Electromyography; Humans; Levodopa; Male; Manganese Poisoning; Metallurgy; Middle Aged; Occupational Diseases | 1986 |
Hemidystonia: a report of 22 patients and a review of the literature.
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Brain Damage, Chronic; Brain Diseases; Brain Injuries; Carbidopa; Child; Child, Preschool; Dominance, Cerebral; Dystonia; Dystonia Musculorum Deformans; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Tomography, X-Ray Computed; Trihexyphenidyl | 1985 |
Failure of postictal growth hormone rise in a patient with thalamic lesions.
Topics: Adult; Arginine; Brain Diseases; Circadian Rhythm; Growth Hormone; Humans; Levodopa; Male; Postoperative Complications; Seizures; Sleep Stages; Stress, Physiological; Thalamus; Tremor | 1985 |
[L-dopa in the apallic syndrome].
Topics: Brain Diseases; Cerebral Cortex; Decerebrate State; Electric Stimulation; Humans; Levodopa | 1974 |
Levodopa, manganese, and degenerations of the brain.
Topics: Administration, Oral; Animals; Apomorphine; Blood Urea Nitrogen; Brain Diseases; Carbon Radioisotopes; Chemical Phenomena; Chemistry; Chronic Disease; Dietary Proteins; Dopamine; Drug Therapy, Combination; Growth Hormone; Humans; Injections; Levodopa; Manganese Poisoning; Movement Disorders; Neutron Activation Analysis; Parkinson Disease; Psychoses, Substance-Induced; Radioisotopes | 1974 |